Published in Am J Psychiatry on June 01, 1999
Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci (2005) 1.30
Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression. Clin Pract Epidemiol Ment Health (2011) 1.04
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord (2012) 1.04
Repetitive Transcranial Magnetic Stimulation in the Treatment of depression: A Randomized, Double-blind, Placebo-controlled Trial. Indian J Psychol Med (2011) 0.97
"Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatr Dis Treat (2006) 0.92
Prefrontal TMS produces smaller EEG responses than motor-cortex TMS: implications for rTMS treatment in depression. Psychopharmacology (Berl) (2005) 0.91
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ont Health Technol Assess Ser (2016) 0.83
Acute effects of repetitive transcranial magnetic stimulation on attentional control are related to antidepressant outcomes. J Psychiatry Neurosci (2009) 0.83
More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013. Neuropsychiatr Dis Treat (2014) 0.79
Repetitive transcranial magnetic stimulation for the treatment of depression. J Psychiatry Neurosci (2005) 0.79
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.77
Managing neuropsychiatric disease with transcranial magnetic stimulation. CMAJ (2000) 0.77
Repetitive transcranial magnetic stimulation for the treatment of depression: to stimulate or not to stimulate? J Psychiatry Neurosci (2005) 0.77
Short-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in depression- reanalysis of data from meta-analyses up to 2010. BMC Psychol (2014) 0.77
Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study. J Psychiatry Neurosci (2016) 0.76
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations in Patients with Schizophrenia: A Randomized Controlled, Cross-over Study. Clin Psychopharmacol Neurosci (2014) 0.75
No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression. J ECT (2014) 0.75
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord (2015) 0.75
Transcranial magnetic stimulation: a new tool in the fight against depression. Dialogues Clin Neurosci (2002) 0.75
Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc (1966) 17.89
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell (1987) 14.62
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82
Controlled trial of three different antismoking interventions in general practice. Br Med J (Clin Res Ed) (1984) 6.25
Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09
Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J (1999) 5.68
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology (1996) 5.36
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases. Genes Dev (1999) 4.95
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Acid-base titration across the membrane system of rat-liver mitochondria. Catalysis by uncouplers. Biochem J (1967) 4.24
Proton-coupled beta-galactoside translocation in non-metabolizing Escherichia coli. J Bioenerg (1972) 4.24
The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry (1990) 4.10
Estimation of membrane potential and pH difference across the cristae membrane of rat liver mitochondria. Eur J Biochem (1969) 3.97
Translocations through natural membranes. Adv Enzymol Relat Areas Mol Biol (1967) 3.77
Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: power transmission by proticity. Biochem Soc Trans (1976) 3.58
Cooperative hernia study. Pain in the postrepair patient. Ann Surg (1996) 3.57
Performance and conservation of osmotic work by proton-coupled solute porter systems. J Bioenerg (1973) 3.41
Possible molecular mechanisms of the protonmotive function of cytochrome systems. J Theor Biol (1976) 3.41
Keilin's respiratory chain concept and its chemiosmotic consequences. Science (1979) 3.23
Translocation of some anions cations and acids in rat liver mitochondria. Eur J Biochem (1969) 3.13
The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins. Genes Dev (1994) 3.12
Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Chemiosmotic coupling in energy transduction: a logical development of biochemical knowledge. J Bioenerg (1972) 3.02
Proton-translocation phosphorylation in mitochondria, chloroplasts and bacteria: natural fuel cells and solar cells. Fed Proc (1967) 2.96
Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychol Med (2009) 2.93
Proton/sodium ion antiport in Escherichia coli. Biochem J (1974) 2.89
Prevalence and causes of amblyopia in an adult population. Ophthalmology (1998) 2.84
Smoking and age-related macular degeneration: a review of association. Eye (Lond) (2005) 2.77
The polarity of proton translocation in some photosynthetic microorganisms. Eur J Biochem (1969) 2.74
Stoicheiometry of lactose-H+ symport across the plasma membrane of Escherichia coli. Biochem J (1973) 2.57
Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc (1998) 2.51
Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res (2000) 2.47
Acid-base titration across the plasma membrane of Micrococcus denitrificans: factors affecting the effective proton conductance and the respiratory rate. J Bioenerg (1970) 2.45
Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J (2006) 2.34
The protonmotive Q cycle: a general formulation. FEBS Lett (1975) 2.32
Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology (1999) 2.29
"Smoking is a major cause of blindness". Med J Aust (1999) 2.27
The Ninth Sir Hans Krebs Lecture. Compartmentation and communication in living systems. Ligand conduction: a general catalytic principle in chemical, osmotic and chemiosmotic reaction systems. Eur J Biochem (1979) 2.25
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. Diabetologia (2010) 2.23
Stoichiometry of proton translocation through the respiratory chain and adenosine triphosphatase systems of rat liver mitochondria. Nature (1965) 2.19
Respiration-driven proton translocation in Micrococcus denitrificans. J Bioenerg (1971) 2.17
Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol (2009) 2.13
Protonmotive redox mechanism of the cytochrome b-c1 complex in the respiratory chain: protonmotive ubiquinone cycle. FEBS Lett (1975) 2.07
Knowledge and beliefs about common eye diseases. Aust N Z J Ophthalmol (1997) 2.06
Medications and cataract. The Blue Mountains Eye Study. Ophthalmology (1998) 2.05
Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol (2001) 2.00
Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol (2008) 1.98
The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry (2001) 1.97
Randomised controlled trial of effectiveness of Leicester hospital at home scheme compared with hospital care. BMJ (1999) 1.97
British Medical Association enters GM-crop affray. Lancet (1999) 1.94
Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93
Clustering of modified nucleotides at the functional center of bacterial ribosomal RNA. FASEB J (1993) 1.93
The prolongation of QTc-interval by thioridazine. Aust N Z J Psychiatry (2001) 1.90
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care (2001) 1.84
Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol (1998) 1.84
Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J (1995) 1.82
Retinopathy predicts coronary heart disease mortality. Heart (2008) 1.80
The development of performance and cost indicators for preschool immunisation. Arch Dis Child (1986) 1.77
Development of guidelines to facilitate improved support of South Asian carers by primary health care teams. Qual Health Care (2001) 1.72
Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol (1998) 1.70
Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (1999) 1.70
Propofol and ECT. Br J Psychiatry (1992) 1.68
Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry (1995) 1.67
Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 1.67
Vectorial chemiosmotic processes. Annu Rev Biochem (1977) 1.66
Incidence of nursing home placement in a defined community. Med J Aust (2001) 1.65
The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology (2000) 1.64
The nature of bipolar depression: implications for the definition of melancholia. J Affect Disord (2000) 1.64
The Parental Bonding Instrument. A decade of research. Soc Psychiatry Psychiatr Epidemiol (1990) 1.63
Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial. BMJ (1999) 1.62
Generation of asymmetry during development. Segregation of type-specific proteins in Caulobacter. J Cell Biol (1979) 1.62
Effects of cataract type and location on visual function: the Blue Mountains Eye Study. Eye (Lond) (2004) 1.62
Experiments on hydraulic jumps in turbidity currents near a canyon-fan transition. Science (1989) 1.61
Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms. Br J Surg (1983) 1.59
Magnetic resonance spectroscopy in AD. Neurology (2001) 1.59
Covered expandable tracheal stents in the management of benign tracheal granulation tissue formation. Ann Thorac Surg (2000) 1.59
The life skills profile: a measure assessing function and disability in schizophrenia. Schizophr Bull (1989) 1.57
Proton translocation coupled to ATP hydrolysis in rat liver mitochondria. Eur J Biochem (1968) 1.57
Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry (1996) 1.56
Visual impairment, age-related cataract, and mortality. Arch Ophthalmol (2001) 1.55
Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol (1998) 1.53
Parental characteristics in relation to depressive disorders. Br J Psychiatry (1979) 1.53
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Reliability of long-term recall of participation in physical activity by middle-aged men and women. Am J Epidemiol (1991) 1.51
Renal impairment and anaemia in a population-based study of older people. Intern Med J (2004) 1.51
What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry (2001) 1.51
Cystadenomas of the liver: a spectrum of disease. Can J Surg (2001) 1.51
The role of smart cards in France. Health Data Manag (1998) 1.49
Retinal microvascular changes and subsequent vascular events after ischemic stroke. Neurology (2011) 1.49
Synthesis of adenosine triphosphate by a protonmotive force in rat liver mitochondria. Nature (1966) 1.48
Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol (1999) 1.48
Continuity and change in medical care for young adults with disabilities. J R Coll Physicians Lond (1987) 1.48